Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.48 |
| ▸ | PRMT3 | O60678 | 1/20 | 0.43 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.43 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.43 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.43 |
| ▸ | PRMT8 | Q9NR22 | 1/20 | 0.43 |
| ▸ | KDM5A | P29375 | 4/20 | 0.37 |
| ▸ | PHF8 | Q9UPP1 | 2/20 | 0.35 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.35 |
| ▸ | CA12 | O43570 | 2/20 | 0.34 |
| ▸ | CA1 | P00915 | 2/20 | 0.34 |
| ▸ | CA9 | Q16790 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL681618 | 1.00 | EPHX1 (0.48) | EPHX1PRMT3CARM1PRMT6PRMT1 | |
| SCHEMBL20118741 | 0.95 | EPHX1 (0.44) | EPHX1PRMT3CARM1PRMT6PRMT1 | |
| SCHEMBL19575770 | 0.90 | EPHX1 (0.44) | EPHX1PRMT3CARM1PRMT6PRMT1 | |
| SCHEMBL12478475 | 0.90 | EPHX1 (0.44) | EPHX1PRMT3CARM1PRMT6PRMT1 | |
| SCHEMBL681370 | 0.90 | EPHX1 (0.55) | EPHX1PRMT3CARM1PRMT6PRMT1 | |
| SCHEMBL27427924 | 0.89 | EPHX1 (0.39) | EPHX1PRMT3CARM1PRMT6PRMT1 | |
| SCHEMBL20283561 | 0.89 | EPHX1 (0.39) | EPHX1PRMT3CARM1PRMT6PRMT1 | |
| SCHEMBL23223465 | 0.89 | EPHX1 (0.39) | EPHX1PRMT3CARM1PRMT6PRMT1 | |
| SCHEMBL12559633 | 0.89 | EPHX1 (0.39) | EPHX1PRMT3CARM1PRMT6PRMT1 | |
| SCHEMBL18732127 | 0.88 | EPHX1 (0.48) | EPHX1PRMT3CARM1PRMT6PRMT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12037641-B2 | Modified nucleotide reagents | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) | 2024-07-16 | — | — | US | disclosed |
| US-20230192749-A1 | PROTECTED FLUORESCENT REAGENT COMPOUNDS | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) | 2023-06-22 | — | — | US | disclosed |
| US-20210369867-A1 | LIPID NANOPARTICLE FORMULATIONS COMPRISING LIPIDATED CATIONIC PEPTIDE COMPOUNDS FOR NUCLEIC ACID DELIVERY | NUTCRACKER THERAPEUTICS, INC. (US) | 2021-12-02 | — | — | US | disclosed |
| US-9957291-B2 | Protected fluorescent reagent compounds | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) | 2018-05-01 | — | — | US | disclosed |
| US-20170321268-A1 | MODIFIED NUCLEOTIDE REAGENTS | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | 2017-11-09 | — | — | US | disclosed |
| US-20170145495-A1 | PROTECTED DYE-LABELED REAGENTS | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | 2017-05-25 | — | — | US | disclosed |
| US-20170145502-A1 | MODIFIED NUCLEOTIDE REAGENTS | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | 2017-05-25 | — | — | US | disclosed |
| US-20160237279-A1 | MULTIMERIC PROTECTED FLUORESCENT REAGENTS | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) | 2016-08-18 | — | — | US | disclosed |
| US-20150050659-A1 | PROTECTED FLUORESCENT REAGENT COMPOUNDS | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | 2015-02-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170321268-A1 | MODIFIED NUCLEOTIDE REAGENTS | POLL, POLN, POLM | EPHX1 4179/4885PRMT3 3919/4885CARM1 4673/4885 |
| US-20150050659-A1 | PROTECTED FLUORESCENT REAGENT COMPOUNDS | ERCC4, ERCC2, ERCC1 | EPHX1 1999/4885PRMT3 3851/4885CARM1 2894/4885 |
| US-12037641-B2 | Modified nucleotide reagents | POLL, POLN, POLM | EPHX1 4179/4885PRMT3 3919/4885CARM1 4673/4885 |
| US-20170145495-A1 | PROTECTED DYE-LABELED REAGENTS | POLL, POLB, POLM | EPHX1 3740/4885PRMT3 4186/4885CARM1 4690/4885 |
| US-20230192749-A1 | PROTECTED FLUORESCENT REAGENT COMPOUNDS | ERCC4, ERCC2, ERCC1 | EPHX1 1999/4885PRMT3 3851/4885CARM1 2894/4885 |
| US-20210369867-A1 | LIPID NANOPARTICLE FORMULATIONS COMPRISING LIPIDATED CATIONIC PEPTIDE COMPOUNDS FOR NUCLEIC ACID DELIVERY | PHOSPHO1, PLIN3, CETP | EPHX1 4154/4885PRMT3 432/4885CARM1 3283/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.